Form 4 for CYRX Cryoport, Inc.
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-14 · accession 0001104659-25-025193 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-18 | 2025-03-17 | CYRX | Sawicki Mark W | CSO | S - Sale | $6.29 | -2,092 | 85.4K | -2% | -$13.2K |
| D | 2025-03-18 | 2025-03-14 | CYRX | Sawicki Mark W | CSO | A - Grant | $0.00 | +9,000 | 87.5K | +11% | $0 |
| D | 2025-03-18 | 2025-03-14 | CYRX | Sawicki Mark W | CSO | A - Grant | $0.00 | +24.0K | 24.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-17 | S | D | 2,092 | $6.29 | 85,436 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-14 | A | A | 9,000 | $0.00 | 87,528 | D | — | — | (F1) Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026. |
| 3 | Derivative | Stock Option (right to buy) | 2025-03-14 | A | A | 24,000 | $0.00 | 24,000 | D | $7.05 · — to 2032-03-14 | 24,000 Common Stock | (F3) 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025. |